TMS for Fibromyalgia

What is Fibromyalgia and How TMS Helps

Fibromyalgia is pain that doesn’t play by the rules. There’s no damaged tissue causing it. No broken bone, no torn ligament. Instead, your brain and spinal cord are amplifying pain signals — turning up the volume on everything until normal sensory input registers as painful. About 4 million adults in the US live with this. That’s roughly 2% of the adult population.

The symptoms go beyond pain: crushing fatigue, “fibro fog” that makes thinking feel like wading through mud, and sleep that never seems to restore you. Neuroimaging shows measurable brain differences — increased activity in pain-processing regions like the insula and anterior cingulate cortex, reduced gray matter in the prefrontal cortex, and disrupted connections between brain areas that should be dampening pain. Your brain’s natural pain braking system isn’t working properly. Pain persists and amplifies unchecked.

The FDA-approved medications — duloxetine (Cymbalta), milnacipran (Savella), and pregabalin (Lyrica) — help some people, along with exercise, CBT, and sleep management. But let’s be honest about the numbers: only 30-40% of people get a 30% or greater pain reduction from any single medication. And side effects — weight gain, drowsiness, nausea, cognitive dulling — push many people to stop taking them.

Since fibromyalgia is fundamentally a central nervous system problem, TMS makes real sense as an approach. It directly modulates the brain circuits driving amplified pain processing. Stimulating the motor cortex or prefrontal cortex activates your brain’s descending pain inhibition pathways — essentially telling the brain to turn the volume back down.

How TMS Works for Fibromyalgia

Two primary brain targets, each tackling different parts of the problem:

Primary Motor Cortex (M1) Stimulation

This is the most studied approach. High-frequency rTMS (10-20 Hz) goes to the left primary motor cortex. M1 connects densely to the thalamus, periaqueductal gray, and other structures involved in top-down pain control. Stimulating it activates those inhibitory pathways.

A detail that surprises people: the coil targets the hand area of M1, regardless of where your fibromyalgia pain is worst. That’s because the pain relief works through central network modulation — it’s changing how your brain processes pain globally, not treating a specific body part.

Dorsolateral Prefrontal Cortex (DLPFC) Stimulation

Same target as depression treatment (left DLPFC, 10 Hz). This one goes after the emotional, cognitive, and mood dimensions of fibromyalgia — depression, catastrophizing, fatigue, cognitive dysfunction. Given that 50-70% of people with fibromyalgia also have depression, and the two conditions share overlapping brain circuits, DLPFC stimulation can cast a wider net across symptoms.

Dual-Target Protocols

Some clinicians combine both targets in a single session or alternating sessions — motor cortex for pain, DLPFC for mood and cognition.

Typical Protocol Parameters

Clinical Evidence and Success Rates

Among off-label TMS applications, fibromyalgia has some of the strongest evidence. Over 35 clinical trials, multiple randomized controlled studies, and several meta-analyses.

A 2023 meta-analysis in Pain Medicine looked at 15 randomized controlled trials of motor cortex rTMS for fibromyalgia:

• Mean pain reduction of 30% on visual analog scale scores vs. sham
• Statistically significant improvement (standardized mean difference of -0.68, p < 0.001)
• Number needed to treat (NNT) of about 4 — one in every four people treated gets clinically meaningful relief
• Effects comparable in size to FDA-approved fibromyalgia medications

A 2021 meta-analysis in the European Journal of Pain compared the two targets head-to-head:

• Motor cortex stimulation produced greater pain reduction
• DLPFC stimulation produced greater improvements in depression, fatigue, and quality of life
• Combined protocols showed promise but need more study

Some landmark individual studies:

• Mhalla et al. (2011): 40 patients, active vs. sham M1 rTMS. Active treatment produced 38% pain reduction maintained for 6 weeks, versus 8% in sham
• Short et al. (2011): 20 sessions of left DLPFC rTMS improved depression, pain, and quality of life, with improvements lasting at 2-month follow-up
• A 2022 Brazilian RCT of 60 patients found motor cortex rTMS combined with exercise therapy beat either treatment alone by a significant margin

TMS for fibromyalgia is not FDA-cleared. The European Federation of Neurological Societies has issued “probable efficacy” recommendations for motor cortex rTMS in fibromyalgia pain, and several European guidelines include it as a treatment option.

Who Qualifies for TMS Treatment

No standardized criteria exist since this is off-label. Most providers look for:

• Confirmed fibromyalgia diagnosis based on American College of Rheumatology criteria, ideally from a rheumatologist or pain specialist
• Medications haven’t been enough — you’ve tried at least 2 FDA-approved fibromyalgia meds (duloxetine, milnacipran, or pregabalin) without adequate improvement
• You’ve tried non-drug approaches too — exercise programs, CBT, sleep hygiene
• Realistic expectations — TMS aims for 30-50% pain reduction, not elimination
• You can commit to the schedule — daily sessions for 2-4 weeks, plus potential maintenance

Standard TMS contraindications apply: metallic implants near the head, seizure history, implanted neurostimulators. You don’t need to stop your fibromyalgia medications before starting TMS — they can run alongside each other.

Here’s a useful angle: if you have both fibromyalgia and treatment-resistant depression (and many people do), TMS might be covered under the depression diagnosis while also helping with pain and cognitive symptoms.

What to Expect During Treatment

Here’s how a fibromyalgia TMS course typically unfolds:

Initial evaluation (visit 1): The provider reviews your fibromyalgia diagnosis, pain history, medication trials, and overall health. You’ll fill out baseline assessments — pain rating scales, fatigue measures, the Fibromyalgia Impact Questionnaire, depression screening.

Motor threshold mapping (first treatment visit): The TMS coil locates your motor cortex and determines the minimum stimulation intensity needed to make your thumb twitch. Takes 10-15 minutes.

Treatment sessions: For motor cortex protocols, the coil goes over the left M1 hand area. Each session runs 20-30 minutes. You’ll feel tapping on your scalp and hear clicking. Most people tolerate it well, though the first 2-3 sessions can be mildly uncomfortable as you adjust.

Treatment timeline:

• Week 1-2: Daily sessions (10 total). Some people notice sleep quality improving first.
• Week 3-4: Continued daily sessions if using a 20-session protocol. Pain reduction starts to emerge here.
• Month 2-3: Transition to maintenance — twice-weekly, then weekly sessions.
• Month 4+: Ongoing maintenance as needed, typically weekly or biweekly.

An interesting pattern: sleep and fatigue often improve before pain does. Fibro fog may lift during the treatment course too. Pain relief tends to build gradually over weeks rather than arriving all at once.

One key difference from depression TMS: fibromyalgia generally requires maintenance sessions to keep benefits going. Studies show improvements start fading 1-3 months after stopping treatment without maintenance.

Side Effects and Safety

The side effect profile is especially relevant here, because people with fibromyalgia are often highly sensitive to medication side effects. TMS avoids most of them.

Common side effects:

• Scalp discomfort at the stimulation site (20-30%, usually mild)
• Headache after sessions (15-20%, usually responds to acetaminophen)
• Lightheadedness (less than 10%)
• Transient increase in pain sensitivity during the first 1-2 sessions (uncommon but documented)

Rare side effects:

• Seizure (less than 0.1% across all TMS applications)
• Hearing changes (prevented with standard ear protection)

How it compares to fibromyalgia medications:

No GI problems. No weight changes. No sedation. No cognitive impairment. For a population that often can’t tolerate standard medications, that matters.

TMS Devices Used for Fibromyalgia

No device has FDA clearance for fibromyalgia — all use is off-label:

• MagVenture MagPro: Used in many fibromyalgia research studies. The Cool B65 figure-8 coil handles motor cortex stimulation without overheating during longer sessions.
• Magstim Rapid2: Another workhorse in motor cortex research. Air-cooled coils allow uninterrupted stimulation.
• NeuroStar TMS Therapy System: The most widely available clinical TMS device, mainly set up for DLPFC depression work. Can be repositioned for motor cortex stimulation by experienced operators.
• BrainsWay Deep TMS (H-coil): Under investigation for fibromyalgia. The deeper, broader stimulation pattern might offer additional benefit for motor cortex work. Early studies are interesting.

For fibromyalgia specifically, the motor cortex protocols need different coil positioning than standard depression treatment. Your provider should have experience with M1 targeting — ideally using neuronavigation or established scalp measurement methods to ensure accurate placement.

Cost and Insurance Coverage

TMS for fibromyalgia generally isn’t covered by US insurance due to the lack of FDA clearance for pain:

The depression angle — worth knowing about:

Fibromyalgia and depression overlap heavily, which creates a potential coverage pathway. If you have documented treatment-resistant depression alongside fibromyalgia, TMS for depression is typically covered by insurance after meeting prior authorization requirements. A provider using DLPFC protocols for depression may also improve your pain and other fibromyalgia symptoms simultaneously.

Some providers design dual-target protocols (M1 for pain + DLPFC for depression) where the depression component gets billed to insurance. This requires careful documentation and isn’t universally accepted by insurers.

Other ways to reduce costs:

• Clinical trial participation (search ClinicalTrials.gov for “TMS fibromyalgia”)
• Package pricing and payment plans
• Reduced maintenance session rates
• Employer or disability accommodation programs

Finding a TMS Provider

Choosing the right provider for fibromyalgia TMS requires asking specific questions:

• Motor cortex experience — this is the most important thing. Standard depression TMS targets the DLPFC; fibromyalgia primarily targets the motor cortex. Ask specifically about M1 stimulation experience and how many fibromyalgia or chronic pain patients they’ve treated.
• Pain medicine knowledge — providers who understand central sensitization and fibromyalgia can better select candidates and fit TMS into a broader plan
• Published protocol adherence — ask which study protocol they follow. Good providers base their approach on specific published trials (e.g., the Mhalla protocol for M1 stimulation)
• Outcome tracking — they should use standardized instruments (Fibromyalgia Impact Questionnaire, pain visual analog scale, fatigue measures) to track your response objectively
• Multidisciplinary integration — TMS for fibromyalgia works best combined with exercise, sleep management, stress reduction, and appropriate medications. Look for providers who coordinate with your rheumatologist or pain specialist.

Ask directly: Do you target the motor cortex or DLPFC for fibromyalgia? How many fibromyalgia patients have you treated? What response rates have you seen? Do you offer maintenance? What do you do when someone doesn’t respond?

Frequently Asked Questions

How does TMS for fibromyalgia compare to FDA-approved medications?

In meta-analyses, pain reduction with motor cortex rTMS (about 30%) is comparable to what you’d see with duloxetine, milnacipran, and pregabalin in trials. The difference is side effects — TMS avoids the systemic effects that drive many people off their medications. And you can use TMS and medications together.

Will TMS help my fibro fog?

Several studies report cognitive improvements during and after TMS, especially with DLPFC stimulation — better attention, processing speed, and working memory. But it’s not universal, and how much improvement you’ll see varies.

How long do the effects last?

Without maintenance sessions, pain relief from a single treatment course typically lasts 1-3 months. Regular maintenance (weekly to biweekly) can sustain improvement long-term. That ongoing commitment is one of the key practical considerations.

Is TMS for fibromyalgia the same as TMS for depression?

No. The primary target for fibromyalgia is the motor cortex (M1), not the DLPFC used in depression. The coil position differs, and in some protocols the stimulation parameters do too. A provider running standard depression protocols without adjusting for motor cortex targeting is not giving you an optimized fibromyalgia treatment.

Can I do TMS while continuing my current fibromyalgia medications?

Yes. TMS is safe alongside duloxetine, pregabalin, milnacipran, gabapentin, and other common fibromyalgia medications. No known interactions. Some people find TMS allows them to reduce medication doses over time — but make any changes gradually, with your doctor guiding the process.